Moderna, Inc. (MRNA)
USD 25.72
(4.98%)
USD 25.72
(4.98%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.9 Billion USD | 23.46% |
| 2022 | -2 Billion USD | 66.2% |
| 2021 | -5.93 Billion USD | -145.47% |
| 2020 | -2.41 Billion USD | -2234.57% |
| 2019 | -103.51 Million USD | 83.43% |
| 2018 | -624.87 Million USD | -424.35% |
| 2017 | -119.17 Million USD | -217.12% |
| 2016 | -37.58 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.47 Billion USD | -20.82% |
| 2024 Q1 | -2.05 Billion USD | 29.45% |
| 2023 Q1 | -3.44 Billion USD | -7.36% |
| 2023 FY | -1.66 Billion USD | 17.01% |
| 2023 Q4 | -2.9 Billion USD | 0.85% |
| 2023 Q3 | -2.93 Billion USD | 22.86% |
| 2023 Q2 | -3.8 Billion USD | -10.46% |
| 2022 Q1 | -4.1 Billion USD | 30.87% |
| 2022 FY | -2 Billion USD | 66.2% |
| 2022 Q4 | -2 Billion USD | -13.53% |
| 2022 Q3 | -1.76 Billion USD | 11.08% |
| 2022 Q2 | -1.98 Billion USD | 51.57% |
| 2021 Q3 | -4.96 Billion USD | 0.66% |
| 2021 Q4 | -5.93 Billion USD | -19.43% |
| 2021 FY | -5.93 Billion USD | -145.47% |
| 2021 Q1 | -5.2 Billion USD | -115.51% |
| 2021 Q2 | -5 Billion USD | 3.99% |
| 2020 Q3 | -1.29 Billion USD | 18.86% |
| 2020 FY | -2.41 Billion USD | -2234.57% |
| 2020 Q2 | -1.59 Billion USD | -553.57% |
| 2020 Q1 | -243.87 Million USD | -135.6% |
| 2020 Q4 | -2.41 Billion USD | -86.85% |
| 2019 FY | -103.51 Million USD | 83.43% |
| 2019 Q4 | -103.51 Million USD | 26.02% |
| 2019 Q3 | -139.91 Million USD | -18.53% |
| 2019 Q2 | -118.03 Million USD | 74.86% |
| 2019 Q1 | -469.55 Million USD | 24.86% |
| 2018 Q4 | -624.87 Million USD | -345.8% |
| 2018 FY | -624.87 Million USD | -424.35% |
| 2018 Q1 | 756.02 Million USD | 734.4% |
| 2018 Q2 | -113.93 Million USD | -115.07% |
| 2018 Q3 | -140.16 Million USD | -23.02% |
| 2017 Q1 | 1.05 Billion USD | 0.0% |
| 2017 Q4 | -119.17 Million USD | 0.0% |
| 2017 FY | -119.17 Million USD | -217.12% |
| 2016 FY | -37.58 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 61.25 Million USD | 4845.58% |
| Aptorum Group Limited | 1.35 Million USD | 214315.288% |
| Elevation Oncology, Inc. | -19.11 Million USD | -15105.565% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 255.46% |
| AlloVir, Inc. | -62.69 Million USD | -4536.955% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 68020.561% |
| AbCellera Biologics Inc. | -55.94 Million USD | -5096.639% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 20744.841% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -33927.158% |
| Fortress Biotech, Inc. | 7.66 Million USD | 38025.636% |
| ContextLogic Inc. | -232 Million USD | -1153.017% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -1785.874% |
| Incyte Corporation | -3.17 Billion USD | 8.444% |
| Novavax, Inc. | -298.29 Million USD | -874.542% |
| Seer, Inc. | -4.24 Million USD | -68461.321% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -49507.509% |
| Summit Therapeutics Inc. | 34.67 Million USD | 8483.803% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -42631.148% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 23999.829% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -47854.47% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -11993.855% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 42263.444% |
| Vaxcyte, Inc. | -368.22 Million USD | -689.459% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -1099.441% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 10559.468% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -1558.963% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -125362.5% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -15596.666% |
| Agenus Inc. | 274.13 Million USD | 1160.423% |
| Acelyrin, Inc. | -216.9 Million USD | -1240.23% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -51715.716% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -168519.49% |
| Senti Biosciences, Inc. | 1.74 Million USD | 167168.966% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 462998.089% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -2383.639% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -18145.152% |
| IO Biotech, Inc. | -140.69 Million USD | -1966.113% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 2721.99% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 22057.852% |
| Alkermes plc | -166.73 Million USD | -1643.443% |
| Ardelyx, Inc. | 34.51 Million USD | 8523.157% |
| Bicycle Therapeutics plc | -481.46 Million USD | -503.78% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -2151.499% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 8138.603% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -5127.101% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -3653.341% |
| Chimerix, Inc. | -25.51 Million USD | -11292.405% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 41818.833% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -12177.738% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -670.697% |
| CRISPR Therapeutics AG | -150.84 Million USD | -1827.144% |
| Precision BioSciences, Inc. | -85.41 Million USD | -3303.583% |
| Fortress Biotech, Inc. | 7.66 Million USD | 38025.636% |
| GlycoMimetics, Inc. | -40.98 Million USD | -6992.938% |
| ChromaDex Corporation | -24.04 Million USD | -11988.323% |
| Dyadic International, Inc. | -6.37 Million USD | -45477.844% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -2529.889% |
| GT Biopharma, Inc. | -1.02 Million USD | -284620.862% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -5103.709% |
| Immix Biopharma, Inc. | -17.5 Million USD | -16502.14% |
| Innoviva, Inc. | 255.56 Million USD | 1237.489% |
| Jaguar Health, Inc. | 29.39 Million USD | 9990.783% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -59117.763% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 16924.864% |
| MiMedx Group, Inc. | -33.9 Million USD | -8474.968% |
| MEI Pharma, Inc. | -3.7 Million USD | -78361.538% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -817.895% |
| Onconetix, Inc. | 5.33 Million USD | 54625.637% |
| Opthea Limited | 28.15 Million USD | 10424.09% |
| ESSA Pharma Inc. | -33.62 Million USD | -8546.232% |
| Pharming Group N.V. | 109.8 Million USD | 2747.445% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -16610.738% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -17214.909% |
| Lantern Pharma Inc. | -21.7 Million USD | -13294.29% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -5656.322% |
| PureTech Health plc | -167.19 Million USD | -1638.668% |
| PDS Biotechnology Corporation | -32.7 Million USD | -8787.489% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 28613.977% |
| NextCure, Inc. | -6.47 Million USD | -44781.89% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -15596.666% |
| ImmuCell Corporation | 10.99 Million USD | 26549.967% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -40843.662% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 54568.803% |
| Precigen, Inc. | -481 Thousand USD | -604265.904% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -20880.081% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -45471.406% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -1474.697% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 1897.307% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 2913830.718% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -9443.664% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 23335.553% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -1627.961% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -38170.142% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 4814.105% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -4188.686% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -2068.125% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -9968.579% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -3858715.409% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -9319.351% |
| Aptose Biosciences Inc. | -8.19 Million USD | -35373.468% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -92804.547% |
| Soligenix, Inc. | -4.95 Million USD | -58608.332% |
| Century Therapeutics, Inc. | 847 Thousand USD | 343311.334% |
| Kura Oncology, Inc. | -20.11 Million USD | -14349.746% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -7003.064% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -34515.385% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 159676.658% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -90828.996% |
| Autolus Therapeutics plc | -186.59 Million USD | -1457.886% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -5796.073% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -954.048% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 8583.133% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 1868.592% |
| GRI Bio, Inc. | -1.79 Million USD | -161940.134% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -32260.961% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -8641.017% |
| IGM Biosciences, Inc. | -72.6 Million USD | -3903.801% |
| INmune Bio, Inc. | -25.41 Million USD | -11339.928% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 2025.79% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -5638.368% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -17789.922% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -100665.15% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 7746.981% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -6958.395% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 9217.14% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 869.147% |
| Verastem, Inc. | -37.27 Million USD | -7698.165% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -31940.119% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -5505.26% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -19107.136% |
| Histogen Inc. | -7.48 Million USD | -38727.301% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -13354.085% |
| Surrozen, Inc. | -32.66 Million USD | -8799.706% |
| Organovo Holdings, Inc. | -1.5 Million USD | -192799.801% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -69056.853% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 15432.11% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 111223.853% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 70047.064% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -34584.978% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -6591.681% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -19842.567% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -817.645% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -402498.122% |
| Apollomics, Inc. | -27.39 Million USD | -10511.425% |
| Amarin Corporation plc | -191.04 Million USD | -1421.671% |
| Mesoblast Limited | 55.96 Million USD | 5294.504% |
| Turnstone Biologics Corp. | -14.58 Million USD | -19832.803% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -11393.753% |
| Synaptogenix, Inc. | -28.66 Million USD | -10042.526% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -310476.923% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 6065.279% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -337104.163% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -39907.817% |
| Exelixis, Inc. | -73.05 Million USD | -3879.466% |
| Better Therapeutics, Inc. | -860 Thousand USD | -337923.256% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -12005.943% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -1104.37% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 395037.411% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -38982.378% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 231918.182% |
| Gritstone bio, Inc. | 39.49 Million USD | 7461.357% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -3356.558% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -110342.454% |
| Avid Bioservices, Inc. | 169.72 Million USD | 1812.74% |
| Insmed Incorporated | 721.62 Million USD | 502.844% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -31699.991% |
| MediWound Ltd. | -5.32 Million USD | -54522.322% |
| OmniAb, Inc. | 9.2 Million USD | 31687.526% |
| Alector, Inc. | -35.63 Million USD | -8057.252% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 3481.373% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -58889.448% |
| Zai Lab Limited | -775 Million USD | -275.097% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 953.607% |
| Aura Biosciences, Inc. | -21.52 Million USD | -13405.226% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -3424.491% |
| Immunic, Inc. | -45.34 Million USD | -6311.557% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -1404.542% |
| Veracyte, Inc. | -203.82 Million USD | -1326.23% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 555.433% |
| FibroGen, Inc. | 56.76 Million USD | 5220.933% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 32744.582% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -102726.872% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -140311.177% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 163.329% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -86909.877% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -1651.585% |
| TG Therapeutics, Inc. | 17.86 Million USD | 16374.773% |
| Galecto, Inc. | -21.21 Million USD | -13601.923% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -12121.989% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 285.23% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -11778.882% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -25162.883% |
| XBiotech Inc. | -200.02 Million USD | -1353.333% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -3356.558% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 64300.53% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -8143.768% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -3664.666% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 51180.654% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -1605.836% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -3046.989% |
| Vaxxinity, Inc. | 10.13 Million USD | 28791.275% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 494.83% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -26897.783% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -4307.484% |
| NexImmune, Inc. | -3.13 Million USD | -92667.428% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -84095.636% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -19137.069% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -10626.937% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -32286.172% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -2333434.016% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -7065.04% |
| Ainos, Inc. | 4.07 Million USD | 71386.202% |
| Pluri Inc. | 22.82 Million USD | 12833.803% |
| Prothena Corporation plc | -608.34 Million USD | -377.852% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -2347.876% |
| Celularity Inc. | 65.19 Million USD | 4559.273% |
| Rallybio Corporation | -24.1 Million USD | -11961.24% |
| Cue Biopharma, Inc. | -33.81 Million USD | -8495.76% |
| MeiraGTx Holdings plc | -40.3 Million USD | -7113.042% |
| Omeros Corporation | 331.17 Million USD | 977.781% |
| Humacyte, Inc. | -22.48 Million USD | -12828.044% |
| Immunocore Holdings plc | -358.59 Million USD | -710.666% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -11729.095% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -9307.463% |
| Blueprint Medicines Corporation | 702.83 Million USD | 513.61% |
| CalciMedica, Inc. | -5.53 Million USD | -52467.812% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -1444.469% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -28360.936% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -7160.784% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -8642.068% |
| Pulmatrix, Inc. | -10.41 Million USD | -27806.307% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -48536.44% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -7521.52% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -2509.468% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -4749.525% |
| Cytokinetics, Incorporated | 642.37 Million USD | 552.542% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -49822.72% |
| Nutriband Inc. | -251.65 Thousand USD | -1155043.708% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -8420.179% |
| Vor Biopharma Inc. | 4.3 Million USD | 67704.651% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 51.839% |
| Evogene Ltd. | -19.63 Million USD | -14705.949% |
| ProKidney Corp. | -56.23 Million USD | -5069.287% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -5872.633% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -31370.62% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 313.138% |
| CorMedix Inc. | -43.05 Million USD | -6652.22% |
| BioLineRx Ltd. | 7.33 Million USD | 39726.499% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -10484.38% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 6399.434% |
| Atai Life Sciences N.V. | -28.55 Million USD | -10079.284% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 130427.828% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -12641.059% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 16491.317% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -3772.179% |
| MediciNova, Inc. | -50.78 Million USD | -5624.298% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -3588.852% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -12922771.749% |
| GeoVax Labs, Inc. | -6.45 Million USD | -44951.684% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -1354.802% |
| Biomea Fusion, Inc. | -166.57 Million USD | -1645.212% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -1524.249% |
| Mereo BioPharma Group plc | -51.46 Million USD | -5548.06% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -2965.033% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -889.587% |
| Absci Corporation | -72.59 Million USD | -3904.243% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 63766.229% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -1139.992% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -2985.627% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -2937.745% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -7339.92% |
| Allakos Inc. | -24.97 Million USD | -11539.64% |
| Imunon, Inc. | -4.21 Million USD | -68886.761% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -19619.17% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -2046.972% |
| BioAtla, Inc. | -109.01 Million USD | -2566.703% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 395037.411% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -309484.665% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 24393.833% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -13610.324% |
| XOMA Corporation | -29 Million USD | -9924.138% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -17454.348% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -32142.68% |
| aTyr Pharma, Inc. | -7.44 Million USD | -38925.373% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -2232.392% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -1296.495% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -3454.702% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -3033.793% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -338244.289% |
| Akari Therapeutics, Plc | -3.84 Million USD | -75504.681% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 179224.894% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 310.518% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -244569.166% |
| UroGen Pharma Ltd. | 4.39 Million USD | 66303.598% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 2661.662% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 4039732.028% |
| Orgenesis Inc. | 21.78 Million USD | 13444.657% |
| Entera Bio Ltd. | -10.62 Million USD | -27249.704% |
| GH Research PLC | -78.07 Million USD | -3623.248% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -12942.893% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -10804.385% |
| Xencor, Inc. | 29.64 Million USD | 9906.369% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -147477.535% |
| Replimune Group, Inc. | 1.41 Million USD | 205978.187% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -1186876.334% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -2199.532% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -244569.166% |
| Portage Biotech Inc. | -4.98 Million USD | -58261.775% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -12922771.749% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -4296.419% |
| OncoCyte Corporation | -6.56 Million USD | -44193.768% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 324031.122% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -63710.97% |
| Purple Biotech Ltd. | -14.13 Million USD | -20461.607% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -12136.909% |
| scPharmaceuticals Inc. | -6.54 Million USD | -44315.584% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -17315.356% |
| HilleVax, Inc. | -165.48 Million USD | -1656.655% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -114439.007% |
| Tharimmune, Inc. | -10.93 Million USD | -26483.506% |
| Genprex, Inc. | -6.73 Million USD | -43045.742% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -688.217% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -3186.231% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -207394.647% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -87540.86% |
| OKYO Pharma Limited | -826.84 Thousand USD | -351476.106% |
| Savara Inc. | 153 Thousand USD | 1900100.0% |
| Curis, Inc. | -23.88 Million USD | -12069.799% |
| Daré Bioscience, Inc. | -5.15 Million USD | -56260.026% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -374507.609% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -46726.675% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 245416.456% |
| BeiGene, Ltd. | -2.25 Billion USD | -29.023% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 23660.4% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -377.965% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -1466.39% |
| Erasca, Inc. | -37.21 Million USD | -7711.156% |
| bluebird bio, Inc. | 108.57 Million USD | 2777.511% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -225617.509% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 867.529% |
| DBV Technologies S.A. | -126.98 Million USD | -2189.229% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -225617.509% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -27981.53% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -26648.252% |
| Molecular Templates, Inc. | 707 Thousand USD | 411273.975% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -9166.52% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 938.7% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -3442.444% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -3069.083% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -8907.809% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -8356.481% |
| MacroGenics, Inc. | -66.98 Million USD | -4239.778% |
| RenovoRx, Inc. | -1.17 Million USD | -247726.087% |
| Adicet Bio, Inc. | -138.78 Million USD | -1994.577% |
| Prime Medicine, Inc. | -27.94 Million USD | -10304.066% |
| Aditxt, Inc. | 18.12 Million USD | 16142.263% |
| Adagene Inc. | -87.62 Million USD | -3217.456% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -69688.747% |
| Quantum-Si incorporated | -118.55 Million USD | -2351.985% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 8173.879% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -38793.857% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -5892.702% |
| SciSparc Ltd. | -2.06 Million USD | -140674.818% |
| Vericel Corporation | 1.27 Million USD | 227742.913% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -24141.765% |
| Minerva Neurosciences, Inc. | 41 Million USD | 7189.509% |
| Generation Bio Co. | 31.44 Million USD | 9343.831% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -1557.695% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -9300.77% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 2593.289% |
| Invivyd, Inc. | -198.47 Million USD | -1364.661% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -3120.339% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -121141.783% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -4006.512% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -42493.407% |
| 2seventy bio, Inc. | 181.71 Million USD | 1699.758% |
| ADMA Biologics, Inc. | 90.06 Million USD | 3327.633% |
| Clene Inc. | 3.34 Million USD | 87135.928% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -31905.891% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -13414.016% |
| GeoVax Labs, Inc. | -6.45 Million USD | -44951.684% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -744.754% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -11080.906% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 1736.216% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -70948.574% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 58216.753% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -55707.257% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -2130.937% |
| Evaxion Biotech A/S | 5.28 Million USD | 55085.545% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -2482.439% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -2114.469% |
| Trevena, Inc. | 2.25 Million USD | 128842.25% |
| Surrozen, Inc. | -32.66 Million USD | -8799.706% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -5543.564% |
| Cingulate Inc. | 3.08 Million USD | 94400.971% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -98878.55% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 40548.031% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -31187.579% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -3564.763% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -2111.454% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -2654.354% |
| Clearmind Medicine Inc. | -3.94 Million USD | -73632.378% |
| Kronos Bio, Inc. | -36.05 Million USD | -7962.906% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 30995.951% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 199465.35% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -5257.933% |
| Statera Biopharma, Inc. | 14.41 Million USD | 20264.526% |
| ImmunityBio, Inc. | 618.22 Million USD | 570.218% |
| Korro Bio, Inc. | -132.94 Million USD | -2086.651% |
| Kineta, Inc. | -4.54 Million USD | -63916.736% |
| BioVie Inc. | -17.73 Million USD | -16293.765% |
| Codexis, Inc. | -43.27 Million USD | -6618.125% |
| Celularity Inc. | 65.19 Million USD | 4559.273% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -91632.408% |
| Celcuity Inc. | 6.78 Million USD | 42953.927% |
| Virax Biolabs Group Limited | -3.36 Million USD | -86290.739% |
| Cibus, Inc. | -8.07 Million USD | -35886.63% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -68639.655% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 63710.503% |
| IN8bio, Inc. | -16.38 Million USD | -17637.507% |
| Kodiak Sciences Inc. | -103.87 Million USD | -2698.556% |
| Annexon, Inc. | -193.75 Million USD | -1400.348% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 8075100.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -16512.378% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -82649.787% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 375.735% |
| Eyenovia, Inc. | 1.25 Million USD | 231052.203% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 10904.683% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -89539.223% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -8643.646% |
| Arcellx, Inc. | -296.95 Million USD | -878.926% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -14803.107% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -4837.58% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -13925.185% |
| Moolec Science SA | 117.61 Thousand USD | 2471702.503% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -7470.51% |
| Geron Corporation | 14.76 Million USD | 19793.788% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -7566.544% |
| Royalty Pharma plc | 5.65 Billion USD | 151.376% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -1955.565% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -41491.41% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -54106.161% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -1965.643% |
| Humacyte, Inc. | -22.48 Million USD | -12828.044% |
| Structure Therapeutics Inc. | -124.33 Million USD | -2237.963% |
| 89bio, Inc. | -289.05 Million USD | -905.698% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -11416.52% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -162939.821% |
| Genelux Corporation | -6.89 Million USD | -42036.542% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -9259.606% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 3577.314% |
| Notable Labs, Ltd. | -9.77 Million USD | -29636.088% |
| Liquidia Corporation | -80.17 Million USD | -3525.773% |
| Mustang Bio, Inc. | -3.73 Million USD | -77710.493% |
| Immunovant, Inc. | -635.22 Million USD | -357.632% |
| Quantum-Si incorporated | -118.55 Million USD | -2351.985% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -16450.9% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -70066.546% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 36315.273% |
| Acasti Pharma Inc. | -23 Million USD | -12536.383% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -86232.115% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -17789.922% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -2010.498% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -93181.846% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -12975.747% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -15555.124% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -1617.293% |
| PepGen Inc. | -60.67 Million USD | -4691.495% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -12552.333% |
| United Therapeutics Corporation | -507.7 Million USD | -472.582% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -15099.205% |
| Solid Biosciences Inc. | -47.75 Million USD | -5987.958% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -337104.163% |
| Immuneering Corporation | -54.94 Million USD | -5190.952% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -69056.853% |
| Silo Pharma, Inc. | -3.52 Million USD | -82384.278% |
| Belite Bio, Inc | -87.27 Million USD | -3231.003% |
| XOMA Corporation | -29 Million USD | -9924.138% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -4011.914% |
| Bionomics Limited | 227 Million USD | 1380.561% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -2399.957% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -114665.101% |
| uniQure N.V. | -102.95 Million USD | -2723.673% |
| Cassava Sciences, Inc. | -121.13 Million USD | -2299.782% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -69688.747% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 7198.728% |
| Forte Biosciences, Inc. | -11.96 Million USD | -24203.988% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -93849.971% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 2742552.83% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -89539.223% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 32744.582% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -39099.029% |
| Altimmune, Inc. | -134.48 Million USD | -2061.547% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 1567.7% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -114665.101% |
| Compugen Ltd. | -12.9 Million USD | -22427.898% |
| Peak Bio, Inc. | 10.34 Million USD | 28213.69% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -1027108.481% |
| Benitec Biopharma Inc. | -50.58 Million USD | -5647.104% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -2686.137% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 14897.658% |
| Zura Bio Limited | -99.8 Million USD | -2812.651% |
| PolyPid Ltd. | 6.17 Million USD | 47215.073% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 4022.018% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 14897.658% |
| Instil Bio, Inc. | 75.35 Million USD | 3957.586% |
| argenx SE | -2.02 Billion USD | -43.284% |
| Immunome, Inc. | -97.02 Million USD | -2896.012% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -12822.872% |
| Verona Pharma plc | -220.44 Million USD | -1218.708% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -3951.963% |
| Shattuck Labs, Inc. | -121.42 Million USD | -2294.09% |
| CervoMed Inc. | -7.79 Million USD | -37203.445% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -1467.124% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -66376.103% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -2106.619% |
| Moolec Science SA | 117.61 Thousand USD | 2471702.503% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -126955.473% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 18384.882% |
| AnaptysBio, Inc. | -18.15 Million USD | -15915.647% |
| Design Therapeutics, Inc. | -18.15 Million USD | -15916.529% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -4030.376% |
| NeurAxis, Inc. | 145.7 Thousand USD | 1995295.607% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 25981.41% |
| Lumos Pharma, Inc. | -28.49 Million USD | -10102.506% |
| Achilles Therapeutics plc | -126.92 Million USD | -2190.347% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -3951.963% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -443222.709% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -13893.571% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 199465.35% |
| Nutriband Inc. | -251.65 Thousand USD | -1155043.708% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -21971.217% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -38972.581% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 954.505% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 12347.735% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -549.65% |
| Palisade Bio, Inc. | -12.06 Million USD | -23998.483% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -1971.826% |
| Beam Therapeutics Inc. | -262.72 Million USD | -1006.493% |
| Neurogene Inc. | -131.95 Million USD | -2103.024% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 13425.083% |
| AEON Biopharma, Inc. | -4.88 Million USD | -59469.672% |
| Sesen Bio, Inc. | -112.55 Million USD | -2482.783% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -2811.076% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -123718.412% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -7348.88% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -3390.55% |
| Athira Pharma, Inc. | -88.99 Million USD | -3166.329% |
| Vaccinex, Inc. | -1.28 Million USD | -225598.758% |
| HCW Biologics Inc. | 2.85 Million USD | 101861.628% |
| XOMA Corporation | -29 Million USD | -9924.138% |
| Nektar Therapeutics | 210.24 Million USD | 1482.705% |
| Arvinas, Inc. | -313.8 Million USD | -826.386% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 179224.894% |
| Merus N.V. | -192.88 Million USD | -1407.123% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 4946.212% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -41799.683% |
| Rezolute, Inc. | -68.16 Million USD | -4164.464% |
| Clene Inc. | 3.34 Million USD | 87135.928% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -21944.438% |
| BeyondSpring Inc. | -13.75 Million USD | -21034.133% |
| Synlogic, Inc. | -6.68 Million USD | -43385.415% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 256449.206% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -34282.022% |
| Peak Bio, Inc. | 10.34 Million USD | 28213.69% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -3427.057% |
| Krystal Biotech, Inc. | -350.23 Million USD | -730.017% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 2441.994% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -1620.159% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -91976.89% |
| MannKind Corporation | 143.89 Million USD | 2120.167% |
| Ikena Oncology, Inc. | -109.15 Million USD | -2563.161% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -38296.513% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -8682.477% |
| Gossamer Bio, Inc. | 180.35 Million USD | 1711.821% |
| CohBar, Inc. | -5.93 Million USD | -48915.88% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -9672.086% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 63766.229% |
| Legend Biotech Corporation | -949.39 Million USD | -206.194% |
| Mural Oncology plc | -255.84 Million USD | -1036.244% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 9123.747% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -61611.334% |
| Disc Medicine, Inc. | -358.28 Million USD | -711.374% |
| Champions Oncology, Inc. | 4.81 Million USD | 60511.471% |
| REGENXBIO Inc. | 54.76 Million USD | 5407.844% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -1080942.888% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -1824.86% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -32156.969% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -3502.989% |
| Vaxart, Inc. | -8.24 Million USD | -35174.845% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -5693.148% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -2185.995% |
| Cellectis S.A. | -43.85 Million USD | -6528.663% |
| Longeveron Inc. | -2.9 Million USD | -99865.612% |
| Repare Therapeutics Inc. | -107.85 Million USD | -2595.21% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 400.193% |
| Inozyme Pharma, Inc. | 12 Million USD | 24316.928% |
| Revolution Medicines, Inc. | -608.2 Million USD | -377.965% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -236241.463% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -996.497% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -1837.07% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -18478.641% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -392737.838% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 69.604% |
| Denali Therapeutics Inc. | -74.86 Million USD | -3782.989% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -24141.765% |
| Veru Inc. | 4.77 Million USD | 60916.294% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -25749.191% |
| Cingulate Inc. | 3.08 Million USD | 94400.971% |
| Passage Bio, Inc. | 4.58 Million USD | 63502.399% |
| Context Therapeutics Inc. | -14.44 Million USD | -20017.888% |
| Exicure, Inc. | 5.84 Million USD | 49800.804% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -1161.85% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -7246.475% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 18626.544% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -4842.113% |
| Nuvalent, Inc. | -335.38 Million USD | -766.76% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 167714.097% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -3802.956% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -32599.663% |
| OmniAb, Inc. | 9.2 Million USD | 31687.526% |
| Anew Medical, Inc. | 1.43 Million USD | 203036.895% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 17845.351% |
| Lipocine Inc. | -4.75 Million USD | -61040.893% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -2546.866% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 19186.074% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -5638.368% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 11778.451% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -43152.492% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -4316.121% |
| Ocugen, Inc. | -32.52 Million USD | -8838.84% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -3297.02% |
| Q32 Bio Inc. | -37.94 Million USD | -7560.483% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -462798.089% |
| Alumis Inc. Common Stock | -13.52 Million USD | -21387.176% |
| Equillium, Inc. | -22.39 Million USD | -12882.315% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -11269.681% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -8809.862% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -1172479.311% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 2268.723% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 91000.563% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 885190.473% |
| Dominari Holdings Inc. | 195 Thousand USD | 1490869.231% |
| Edesa Biotech, Inc. | -5.26 Million USD | -55093.652% |
| vTv Therapeutics Inc. | -8.91 Million USD | -32500.65% |
| Bio-Techne Corporation | 267.74 Million USD | 1185.726% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -17834.481% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -2361.598% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -34494.788% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -22878.421% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -1085.955% |
| Nkarta, Inc. | 57.29 Million USD | 5173.387% |
| BioCardia, Inc. | 212 Thousand USD | 1371326.415% |
| Iterum Therapeutics plc | 13.43 Million USD | 21732.683% |